21st Austria weekly - Valneva Andritz 16/05/2022 [pic1]Valneva: an Austrian/French specialty vaccine company announced that it has received a notice from the European Commission EC of intent to terminate advance purchase agreement APA for Valneva’s inactivated whole-virus COVID-19 candidate VLA2001. The APA provides EC with right if VLA2001 had not marketing authorization Medicines Agency

Related Keywords

Austria , Hernani , Pais Vasco , Spain , United Arab Emirates , Spanish , Austrian , Andritz Limeflash , European Medicines Agency , European Commission , Papelera Guipuzcoana De Zicu , Andritz Limeflash H , Besuchen Sie , Ic1 Valneva , Valneva , Austrian French , European , Commission , Ec , Apa , Valneva Amp Rsquo S , Covid 19 , Vla2001 , The , Medicines , Agency ,